These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 26697911)

  • 1. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical tool for modeling biospecimen user fees.
    Matzke L; Dee S; Bartlett J; Damaraju S; Graham K; Johnston R; Mes-Masson AM; Murphy L; Shepherd L; Schacter B; Watson PH
    Biopreserv Biobank; 2014 Aug; 12(4):234-9. PubMed ID: 25162459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biospecimen User Fees: Global Feedback on a Calculator Tool.
    Matzke LA; Babinszky S; Slotty A; Meredith A; Castillo-Pelayo T; Henderson MK; Simeon-Dubach D; Schacter B; Watson PH
    Biopreserv Biobank; 2017 Feb; 15(1):57-64. PubMed ID: 27576065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank.
    Vaught J; Rogers J; Carolin T; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):24-31. PubMed ID: 21672892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustainability of Biobanks in the Future.
    De Souza YG
    Adv Exp Med Biol; 2015; 864():29-35. PubMed ID: 26420611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biobanking initiatives to develop a national liver disease biobank facility in India.
    Yadav BK; Bihari C
    Per Med; 2018 Nov; 15(6):531-541. PubMed ID: 30394189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience.
    Wilson GD; D'Angelo K; Pruetz BL; Geddes TJ; Larson DM; Akervall J
    Biopreserv Biobank; 2014 Oct; 12(5):306-11. PubMed ID: 25314610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer donor preferences for disposition of their biospecimens after biobank closure.
    Allen SC; Dixon MD; Switchenko JM; Pentz RD
    Cancer; 2017 Dec; 123(23):4648-4652. PubMed ID: 28746751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
    Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA
    Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability.
    Uzarski D; Burke J; Turner B; Vroom J; Short N
    Clin Transl Sci; 2015 Oct; 8(5):553-7. PubMed ID: 25996355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost model for biobanks.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; Morente MM; Fernández Lago O
    Biopreserv Biobank; 2013 Oct; 11(5):272-7. PubMed ID: 24835258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beaumont health system biobank: a multidisciplinary biorepository and translational research facility.
    Akervall J; Pruetz BL; Geddes TJ; Larson D; Felten DJ; Wilson GD
    Biopreserv Biobank; 2013 Aug; 11(4):221-8. PubMed ID: 24845589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biobank and Pathology Facility: A Successful Combination.
    Alves A; Gibbon A; Carvalho S; Rodriguez-Justo M; Miranda E
    J Biomol Tech; 2022 Apr; 33(1):. PubMed ID: 35837002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.